Right Rebate Act of 2018
Official title: To amend title XIX of the Social Security Act to prevent the misclassification of drugs for purposes of the Medicaid drug rebate program.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Right Rebate Act of 2018
This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 7223: Right Rebate Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-7223/
"H.R. 7223: Right Rebate Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-7223/.
H.R. 7223, 115th Cong. (2026), https://openamerica.io/bill/115-HR-7223/.
[H.R. 7223: Right Rebate Act of 2018](https://openamerica.io/bill/115-HR-7223/)